# [BrainConnexion] - Neurodevice Phase I Trial

> **NCT03811301** · NA · UNKNOWN · sponsor: **National Neuroscience Institute** · enrollment: 5 (actual)

## Conditions studied

- Tetraplegia
- Tetraplegia/Tetraparesis
- Spinal Cord Injuries
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
- Locked-in Syndrome
- Muscular Dystrophies

## Interventions

- **DEVICE:** BrainConnexion

## Key facts

- **NCT ID:** NCT03811301
- **Lead sponsor:** National Neuroscience Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-21
- **Primary completion:** 2023-01-27
- **Final completion:** 2023-08-27
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03811301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03811301, "[BrainConnexion] - Neurodevice Phase I Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03811301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*